{"Clinical Trial ID": "NCT02725801", "Intervention": ["INTERVENTION 1:", "Only one port", "The intervention is the placement of a fabric extender at a port at the time of reconstruction", "\u2022 Moving from a tissue extender to an allergen port: patients will be randomized to receive one or two tissue extenders at a port for breast reconstruction", "INTERVENTION 2:", "Two ports", "The intervention is the placement of a fabric extender at two ports at the time of reconstruction", "AlloX2 Two Port Tissue Extensor Placement: Patients will be randomized to receive one or two Two Port Tissue Extensors for Breast Reconstruction"], "Eligibility": ["Incorporation criteria:", "A patient accepts immediate breast reconstruction of a tissue extensor", "A suitable patient for the reconstruction of a tissue extender", "- Exclusion criteria:", "Not a surgical candidate for immediate breast reconstruction", "Under 18 years of age", "The patient declines the reconstruction of the tissue extensor", "Patients in need of post-operative radiotherapy"], "Results": ["Performance measures:", "Number of participants who succeeded in replacing the tissue expander with a permanent implant", "The number of patients who may undergo replacement of the tissue extensor between the two arms will be compared", "Time limit: 3 months", "Results 1:", "Title of the arm/group: One port", "- Arm/group description: the intervention consists of placing a fabric extender at a port at the time of reconstruction", "\u2022 Moving from a tissue extender to an allergen port: patients will be randomized to receive one or two tissue extenders at a port for breast reconstruction", "Total number of participants analysed: 8", "Type of measure: Number of participants", "Unit of measure: Participants 8,100.0%", "Results 2:", "Title of the arm/group: Two ports", "- Arm/group description: the intervention consists of placing a fabric extender at two ports at the time of reconstruction", "AlloX2 Two Port Tissue Extensor Placement: Patients will be randomized to receive one or two Two Port Tissue Extensors for Breast Reconstruction", "Total number of participants analysed: 12", "Type of measure: Number of participants", "Unit of measure: Participants 12 100.0%"], "Adverse Events": ["Undesirable Events 1:", "Total: 1/8 (12.50 per cent)", "Reoperation [1]1/8 (12.50%)", "Adverse Events 2:", "Total: 4/12 (33.33 per cent)", "Reoperation [1]4/12 (33.33%)"]}